306 related articles for article (PubMed ID: 17439414)
21. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
[TBL] [Abstract][Full Text] [Related]
22. [Sensitivity to chemotherapeutic drugs of polyploid tumor cells induced by a spindle poison nocodazole].
Hao J; Yuan BB; Xu YF; Yu J; Liu GY; Wang DH
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):419-24. PubMed ID: 22967442
[TBL] [Abstract][Full Text] [Related]
23. [Bcl-XL antisense oligodeoxynucleotide sensitizes human esophageal cancer cell line to 5-fluorouracil].
Zhang L; Wen HT; Wang LX; Zhang L; Zhang YH
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):173-7. PubMed ID: 16875599
[TBL] [Abstract][Full Text] [Related]
24. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
Rashmi R; Kumar S; Karunagaran D
Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
[TBL] [Abstract][Full Text] [Related]
26. DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells.
Singh S; Chhipa RR; Vijayakumar MV; Bhat MK
Cancer Lett; 2006 May; 236(2):213-21. PubMed ID: 15996812
[TBL] [Abstract][Full Text] [Related]
27. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line.
Biliran H; Wang Y; Banerjee S; Xu H; Heng H; Thakur A; Bollig A; Sarkar FH; Liao JD
Clin Cancer Res; 2005 Aug; 11(16):6075-86. PubMed ID: 16115953
[TBL] [Abstract][Full Text] [Related]
29. Enhanced inhibition of bladder cancer cell growth by simultaneous knockdown of antiapoptotic Bcl-xL and survivin in combination with chemotherapy.
Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
Int J Mol Sci; 2013 Jun; 14(6):12297-312. PubMed ID: 23749114
[TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapy.
Feng X; Zhang B; Wang J; Xu X; Lin N; Liu H
Med Oncol; 2011 Mar; 28(1):24-30. PubMed ID: 20221717
[TBL] [Abstract][Full Text] [Related]
31. Inducing apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z by bcl-xL short hairpin RNA.
He CW; Liu F; Zhang YF; Liang T; Zhou KY
Ai Zheng; 2005 Jun; 24(6):646-52. PubMed ID: 15946471
[TBL] [Abstract][Full Text] [Related]
32. Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer.
Liao X; Tang S; Thrasher JB; Griebling TL; Li B
Mol Cancer Ther; 2005 Apr; 4(4):505-15. PubMed ID: 15827323
[TBL] [Abstract][Full Text] [Related]
33. A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect.
Kim HO; Kim E; An Y; Choi J; Jang E; Choi EB; Kukreja A; Kim MH; Kang B; Kim DJ; Suh JS; Huh YM; Haam S
Macromol Biosci; 2013 Jun; 13(6):745-54. PubMed ID: 23613425
[TBL] [Abstract][Full Text] [Related]
34. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
Kim DW; Seo SW; Cho SK; Chang SS; Lee HW; Lee SE; Block JA; Hei TK; Lee FY
J Orthop Res; 2007 Jun; 25(6):820-8. PubMed ID: 17343283
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.
Cao XX; Mohuiddin I; Ece F; McConkey DJ; Smythe WR
Am J Respir Cell Mol Biol; 2001 Nov; 25(5):562-8. PubMed ID: 11713097
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
[TBL] [Abstract][Full Text] [Related]
37. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
[TBL] [Abstract][Full Text] [Related]
38. Effect of Bcl-2-siRNA on proliferation and apoptosis of pediatric acute B lymphoblastic leukemia (A-BLL) cells.
Meng WB; Liu JP; Wang XW; E LH
Genet Mol Res; 2015 Oct; 14(4):12427-36. PubMed ID: 26505392
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.
Tirado OM; Mateo-Lozano S; Notario V
Oncogene; 2005 May; 24(20):3348-57. PubMed ID: 15782132
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 gene silence enhances the sensitivity toward 5-Fluorouracil in gastric adenocarcinoma cells.
Yu DF; Wu FR; Liu Y; Liu H; Xia Q
Biomed Pharmacother; 2013 Sep; 67(7):615-9. PubMed ID: 23684481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
